Silverlake Wealth Management LLC Trims Holdings in Kenvue Inc. (NYSE:KVUE)

Silverlake Wealth Management LLC cut its stake in Kenvue Inc. (NYSE:KVUE) by 5.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,107 shares of the company’s stock after selling 545 shares during the quarter. Silverlake Wealth Management LLC’s holdings in Kenvue were worth $216,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Grove Bank & Trust grew its position in shares of Kenvue by 438.4% in the fourth quarter. Grove Bank & Trust now owns 1,163 shares of the company’s stock valued at $25,000 after purchasing an additional 947 shares in the last quarter. Riverview Trust Co purchased a new position in Kenvue during the third quarter worth about $30,000. Geneos Wealth Management Inc. purchased a new position in Kenvue during the fourth quarter worth about $29,000. Ashton Thomas Securities LLC purchased a new position in Kenvue during the third quarter worth about $35,000. Finally, Fortitude Family Office LLC grew its position in Kenvue by 106.6% during the fourth quarter. Fortitude Family Office LLC now owns 1,506 shares of the company’s stock worth $32,000 after buying an additional 777 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on KVUE. Citigroup reduced their target price on Kenvue from $25.00 to $21.00 and set a “neutral” rating for the company in a research report on Wednesday, January 15th. Piper Sandler upgraded Kenvue from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $21.00 to $26.00 in a research report on Monday, January 6th. Barclays reduced their target price on Kenvue from $23.00 to $21.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $24.00 price target on shares of Kenvue in a research note on Monday. Finally, Deutsche Bank Aktiengesellschaft lowered Kenvue from a “buy” rating to a “hold” rating and dropped their price target for the stock from $25.00 to $24.00 in a research note on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $23.08.

Kenvue Trading Down 0.4 %

NYSE KVUE opened at $20.74 on Thursday. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.46. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The stock has a 50-day moving average of $21.77 and a 200-day moving average of $21.96. The firm has a market cap of $39.76 billion, a PE ratio of 37.70, a price-to-earnings-growth ratio of 2.05 and a beta of 1.45.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The company had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same quarter in the previous year, the company posted $0.31 EPS. Kenvue’s revenue for the quarter was down .4% on a year-over-year basis. As a group, sell-side analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th will be paid a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.95%. The ex-dividend date of this dividend is Wednesday, February 12th. Kenvue’s dividend payout ratio (DPR) is presently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.